selegiline

(redirected from Anipryl)
Also found in: Medical.

se·leg·i·line

 (sə-lĕj′ə-lēn′)
n.
A selective monoamine oxidase inhibitor, C13H17N, used transdermally as an antidepressant and in its hydrochloride form in conjunction with levodopa and carbidopa to treat patients with Parkinson's disease.

[Probably sele(ctive) (from its being a selective monoamine oxidase inhibitor) + alteration of (par)gyline, a closely related drug (ultimately from Latin arg(entum), silver; see arg- in Indo-European roots from the fact that one of the constituents of pargyline was discovered in a precipitate containing silver + -yl + -ine).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

selegiline

(səˈlɛɡɪˌliːn)
n
(Medicine) a drug used in treating Parkinson's disease, depression and dementia
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
Translations

selegiline

n selegilina
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
When it comes to specific treatment for CCD, only Anipryl (selegiline) is FDA-approved.
Selegiline Given once daily, Vomiting, diarrhea, (Anipryl, usually in the evening restlessness, lethargy, l-depenyl, for cats.
--Potential Treatments: Mitotane, ketoconazole, adrenalectomy, Anipryl, and radiation therapy of pituitary.
Anipryl is approved for the treatment of canine age-related cognitive disorder, and Clomipramine is approved for the treatment of separation anxiety.
This falling out began in 1998 when DAHI's parent company announced that the FDA had approved the drug Anipryl when used to treat canine cognitive dysfunction.
Made by Pfizer, Anipryl has worked (to some extent) in about 75% of dogs with this problem.
Also on January 5 the FDA gave the thumbs up to Pfizer's Anipryl, the first drug approved for doggie Alzheimer's.
The dog drug goes by the trade name Anipryl. It had earlier won approval for use in canine Cushing's disease, a hormonal imbalance, in both Canada and the United States.
The drug Anipryl was approved by the FDA as a treatment for canine cognitive dysfunction and is sometimes effective for dogs, but it hasn't been approved for feline use.
Do not combine DLPA with MAOI drugs like Anipryl, used to treat Cushing's Disease and canine cognitive dysfunction, or amitraz, an ingredient in tick collars.